Cargando…

Following up tumor-specific regulatory T cells in cancer patients

Detalles Bibliográficos
Autores principales:	Zitvogel, Laurence, Tanchot, Corinne, Granier, Clemence, Tartour, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782156/ https://www.ncbi.nlm.nih.gov/pubmed/24073383 http://dx.doi.org/10.4161/onci.25444

Ejemplares similares

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
por: Pere, Helene, et al.
Publicado: (2012)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
por: Terme, Magali, et al.
Publicado: (2012)

Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
por: Kepp, Oliver, et al.
Publicado: (2023)

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients
por: Palle, Juliette, et al.
Publicado: (2021)

Victories and deceptions in tumor immunology: Stimuvax(®)
por: Kroemer, Guido, et al.
Publicado: (2013)

Resident memory T cells, critical components in tumor immunology
por: Mami-Chouaib, Fathia, et al.
Publicado: (2018)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Cross-reactivity between cancer and microbial antigens
por: Zitvogel, Laurence, et al.
Publicado: (2021)

Targeting Resident Memory T Cells for Cancer Immunotherapy
por: Blanc, Charlotte, et al.
Publicado: (2018)

Immune infiltrate in cancer
por: Stoll, Gautier, et al.
Publicado: (2015)

Immunological effects of chemotherapy in spontaneous breast cancers
por: Kroemer, Guido, et al.
Publicado: (2013)

Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling
por: Mougel, Alice, et al.
Publicado: (2022)

The Ultimate Goal of Curative Anti-Cancer Therapies: Inducing an Adaptive Anti-Tumor Immune Response
por: Fridman, Wolf H., et al.
Publicado: (2011)

CXCR6 expressing T cells: Functions and role in the control of tumors
por: Mabrouk, Nesrine, et al.
Publicado: (2022)

Trial watch: Cardiac glycosides and cancer therapy
por: Menger, Laurie, et al.
Publicado: (2013)

Peripheral Selection of T Cell Repertoires: The Role of Continuous Thymus Output
por: Tanchot, Corinne, et al.
Publicado: (1997)

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
por: Terme, Magali, et al.
Publicado: (2013)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade
por: Hirsch, Laure, et al.
Publicado: (2018)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019)

VEGF-A modulates expression of inhibitory checkpoints on CD8(+) T cells in tumors
por: Voron, Thibault, et al.
Publicado: (2015)

Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance
por: Fidelle, Marine, et al.
Publicado: (2023)

Trial Watch: Peptide vaccines in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2013)

An allogeneic NK cell line engineered to express chimeric antigen receptors: A novel strategy of cellular immunotherapy against cancer
por: Badoual, Cécile, et al.
Publicado: (2013)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Failure of immunosurveillance accelerates aging
por: Perez-Lanzon, Maria, et al.
Publicado: (2019)

Immunotherapy of HPV-associated head and neck cancer: Critical parameters
por: Nizard, Mevyn, et al.
Publicado: (2013)

Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4(+) and CD8(+) T-Cell Epitopes
por: Onodi, Fanny, et al.
Publicado: (2018)

COVID-19: a challenge for oncology services
por: Routy, Bertrand, et al.
Publicado: (2020)

Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
por: Fidelle, Marine, et al.
Publicado: (2023)

Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4(+)CD25(+) regulatory T cell proliferation
por: Ghiringhelli, François, et al.
Publicado: (2005)

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
por: Granier, Clemence, et al.
Publicado: (2017)

CXCR6 deficiency impairs cancer vaccine efficacy and CD8(+) resident memory T-cell recruitment in head and neck and lung tumors
por: Karaki, Soumaya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ahel40ppld3a4r3g563r1pohb3